Timelines · the surgical runway
Surgery weight thresholds: using a GLP-1 runway when the operating room sets your deadline
A large share of GLP-1 starts now begin with a surgeon’s sentence: “we operate below BMI 40” (a common ceiling for elective joint replacement), or a bariatric program’s own preparation targets. That converts weight loss from an open-ended project into a runway with a date, and runways reward different math: at 260 lb needing 30 lb, you’re asking for ~11.5% — inside semaglutide’s ~15%-class year and comfortably inside tirzepatide’s ~20%-class, but the timeline decides feasibility, because trial averages accrue over 65–72 weeks, not twelve. Two more clock-facts every surgical candidate needs: anesthesia teams commonly instruct holding weekly GLP-1 doses for about a week before procedures with sedation (slowed gastric emptying raises aspiration concern; protocols vary and continue to evolve — your surgical team’s written instruction wins), and dose-proof pricing matters more here than anywhere, because a fixed date plus a tier ladder equals paying the most exactly when you can’t pause. Not medical advice; your surgeon and prescriber co-own this plan.
The thresholds, decoded
Orthopedic programs publish BMI ceilings because complication curves — infection, wound healing, anesthesia risk — bend upward with BMI, and 40 is the number you’ll hear most for elective knees and hips, with some programs at 45 and some stricter centers at 35. Three things patients routinely miss: the ceiling usually applies to day-of-surgery BMI (so the runway must land and hold, not just touch the number); many programs pair the BMI line with an A1c line (commonly under 7.5–8%) that GLP-1 therapy often helps simultaneously; and thresholds are program policy, not law — a documented, physician-supervised loss trajectory sometimes earns scheduling flexibility a self-directed diet never would. Get your program’s exact requirements in writing, including whether they want the number at consult, at pre-op, or both — that single email determines your real deadline.
Runway math — honest feasibility by the calendar
Work backward from the surgical date. Trial-average trajectories front-load meaningfully but not magically: semaglutide’s program showed roughly a third to half of eventual loss landing in the first ~20 weeks; tirzepatide’s similar. A serviceable planning heuristic — heuristic, not promise — is 1–2 lb/week during active titration for most responders, which prices a 30-lb requirement at roughly four to seven months including the titration ramp. Under six months of runway, the dual agonist’s higher ceiling and the tighter version of your protein-and-training plan both earn their keep; under three months, have the honest conversation with your surgeon about moving the date rather than crash-dieting into an operating room — rapid non-supervised loss right before surgery trades one risk profile for another. And document everything: weekly weights in a file your surgical office can see turns “trust me” into a trajectory.
The perioperative hold — the instruction that surprises everyone
GLP-1 agents slow gastric emptying — that’s partly how they work — and anesthesia teams care intensely about empty stomachs. In recent years anesthesia guidance has commonly translated to: hold weekly agents for about one week before procedures involving sedation; hold daily agents the day of; expect case-by-case adjustments (longer holds for some patients, gastric ultrasound or modified fasting for others), and the guidance keeps evolving. The practical playbook: disclose your GLP-1 to the surgical scheduler at booking, not at pre-op; get the hold instruction in writing; calendar the last permitted dose; and know that a one-week hold barely dents therapeutic effect given the half-lives — this is a safety choreography, not a treatment interruption. Resuming after surgery is your prescriber’s call, typically once you’re eating normally; appetite suppression colliding with post-surgical nutrition needs (protein for healing — the 1.2–1.6 g/kg range does double duty here) is the conversation worth having before, not after.
The bariatric intersection — before, instead, and after
Three distinct scenarios get blurred online. Before: some bariatric programs use GLP-1 therapy to meet their own pre-surgical targets — same runway math, program-supervised. Instead: for a slice of candidates, ~20%-class pharmacotherapy results approach surgical territory without the OR, and “do I still need the surgery” is now a legitimate, evidence-based question to ask the program — ask it with your trajectory data in hand. After: weight regain years post-bariatric-surgery has become one of the best-supported GLP-1 use cases in practice — the anatomy changed, the physiology drifted, and the medication addresses the physiology. In every scenario the coverage question runs first (surgical programs often unlock insurance pathways cash-pay patients can’t — the employer lane and the denial playbook apply), and the cash fallback runs on the same audited boards as everyone else: the $139 dose-proof anchor exists so a fixed surgical date never meets a surprise tier jump. (Compounded — same active ingredient as the brands, not FDA-approved.)
FAQ
What BMI do I need for knee or hip replacement?
Program-specific — BMI 40 is the most common elective ceiling, with 35–45 across stricter and looser centers, usually measured near surgery day. Get your program’s exact written policy.
Do I stop my GLP-1 before surgery?
Anesthesia teams commonly instruct a ~one-week hold for weekly agents before sedation (day-of for dailies), with protocols varying and evolving — your surgical team’s written instruction is the one that counts.
Can I lose 30 pounds in three months for surgery?
That’s above typical supervised trajectories for most people — the honest options are extending the date or accepting the plan may fall short; crash approaches trade risks rather than removing them.